Transfusion policy: When to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization

Transfusion

Volumn 47, Issue 5, 2007, Pages 781-787

  Senzel, Lisa ^a   Boulad, Farid ^b   Wuest, David ^b   Reid, Marion E ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIGEN;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNIZATION; ALLOTYPE; ARTICLE; BLOOD DONOR; BLOOD GROUP; BLOOD GROUP O; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CASE REPORT; CHIMERA; DECISION MAKING; ERYTHROCYTE; FEMALE; HEALTH CARE POLICY; HEMOLYSIS; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; ERYTHROCYTES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMANS; MALE; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247592090     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01190.x     Document Type: Article

References (29)

1. Walters MC, Patience M, Leisenring W, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001 7 : 665 73.
2. Andreani M, Manna M, Lucarelli G, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 1996 87 : 3494 9.
3. Battaglia M, Andreani M, Manna M, et al. Coexistence of two functioning T-cell repertoires in healthy ex-thalassemics bearing a persistent mixed chimerism years after bone marrow transplantation. Blood 1999 94 : 3432 8.
4. Kean LS, Manci EA, Perry J, et al. Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease. Blood 2003 102 : 4582 93.
5. Walters MC. Stem cell therapy for sickle cell disease: transplantation and gene therapy. Hematology (Am Soc Hematol Educ Prog) 2005 : 66 73.
6. Wu CJ, Krishnamurti L, Kutok JL, et al. Evidence for ineffective erythropoiesis in severe sickle cell disease. Blood 2005 106 : 3639 45.
7. Friedberg RC, Andrzejewski CA. Transfusion therapy in hematopoietic progenitor cell transplantation. In : Mintz PD, editor. Transfusion therapy: clinical principles and practice. 2nd ed. Bethesda : American Association of Blood Banks 2005. p. 2 79 96.
8. Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia : Churchill Livingstone 2004. p. 4 88 90.
9. Canals C, Muniz-Diaz E, Martinez C, et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 2004 44 : 1603 11.
10. Bolan CD, Leitman SF, Griffith LM, et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001 98 : 1687 94.
11. Schetelig J, Breitschaft A, Kroger N, et al. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B. Transfusion 2005 45 : 779 87.
12. Worel N, Greinix HT, Schneider B, et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000 40 : 543 50.
13. Worel N, Kalhs P, Keil F, et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 2003 43 : 1153 61.
14. Maciej ZJ, Mielcarek M, Takatu A, et al. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. Br J Haematol 2002 119 : 740 50.
15. Mijovic A. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning. Vox Sang 2002 83 : 358 62.
16. Asfour M, Narvios A, Lichtiger B. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. Medgenmed 2004 6 : 22.
17. Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004 33 : 1169 72.
18. Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion 2002 42 : 198 204.
19. Abou-Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995 35 : 931 5.
20. Perseghin P, Balduzzi A, Galimberti S, et al. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003 32 : 231 6.
21. Ting A, Pun A, Dodds AJ, Atkinson K, Biggs JC. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987 27 : 145 7.
22. de la Rubia J, Arriaga F, Andreu R, et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 2001 41 : 106 10.
23. Lopez AR, Arriaga F, Jimenez C, et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998 38 : 247 51.
24. Girelli G, Arcese W, Bianchi A, et al. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia. Haematologica 1986 71 : 46 9.
25. Moore SB, Motschman TL, Dewald GW, et al. A case of unusually early but temporary humoral immune reconstitution after bone marrow transplantation. Transplantation 1985 39 : 675 7.
26. Izumi N, Fuse I, Furukawa T, et al. Long-term production of pre-existing alloantibodies to E and c after allogenic BMT in a patient with aplastic anemia resulting in delayed hemolytic anemia. Transfusion 2003 43 : 241 5.
27. Raimondi R, Soli M, Lamparelli T, et al. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 2004 34 : 321 9.
28. Griffith LM, McCoy JP Jr., Bolan CD, et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005 128 : 668 75.
29. van Tol MJ, Gerritsen EJ, de Lange GG, et al. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 1996 87 : 818 26.